Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription 29.03.2021 15 Ann Intern Med 4 Antimicrob Agents Chemother 1 Biochem Soc Trans 17 BMJ 1 Drugs 6 Epidemiol Infect 1 J Exp Med 32 J Infect 1 J Infect Dis 1 J Virol 8 J Virol Methods 11 JAMA 9 Lancet 9 MMWR Morb Mortal Wkly Rep 5 N Engl J Med 3 PLoS Comput Biol 1 PLoS Med 44 PLoS One 4 Proc Natl Acad Sci U S A 5 Vaccine 3 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Intern Med

1. FREEDMAN MS, Bernstein H, Ault KA
   Recommended Adult Immunization Schedule, United States, 2021.
   Ann Intern Med. 2021;174:374-384.
   PubMed        
   
   
2. LO B, Sim I
   Ethical Framework for Assessing Manual and Digital Contact Tracing for COVID-19.
   Ann Intern Med. 2020 Oct 20. doi: 10.7326/M20-5834.
   PubMed         Abstract available
   
   
3. MANSOUR O, Tajanlangit M, Heyward J, Mojtabai R, et al
   Telemedicine and Office-Based Care for Behavioral and Psychiatric Conditions During the COVID-19 Pandemic in the United States.
   Ann Intern Med. 2020 Nov 17. doi: 10.7326/M20-6243.
   PubMed        
   
   
4. BUNDGAARD H, Bundgaard JS, Raaschou-Pedersen DET, von Buchwald C, et al
   Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.
   Ann Intern Med. 2020 Nov 18. doi: 10.7326/M20-6817.
   PubMed         Abstract available
   
   
5. FRIEDEN TR, Cash-Goldwasser S
   Of Masks and Methods.
   Ann Intern Med. 2021;174:421-422.
   PubMed        
   
   
6. LAINE C, Goodman SN, Guallar E
   The Role of Masks in Mitigating the SARS-CoV-2 Pandemic: Another Piece of the Puzzle.
   Ann Intern Med. 2020 Nov 18. doi: 10.7326/M20-7448.
   PubMed        
   
   
7. MACPHERSON A, Hutchinson N, Schneider O, Oliviero E, et al
   Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.
   Ann Intern Med. 2020 Nov 24. doi: 10.7326/M20-5350.
   PubMed         Abstract available
   
   
8. RAY JG, Schull MJ, Vermeulen MJ, Park AL, et al
   Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
   Ann Intern Med. 2020 Nov 24. doi: 10.7326/M20-4511.
   PubMed         Abstract available
   
   
9. BOWLES KH, McDonald M, Barron Y, Kennedy E, et al
   Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients.
   Ann Intern Med. 2020 Nov 24. doi: 10.7326/M20-5206.
   PubMed         Abstract available
   
   
10. MACKEY K, Ayers CK, Kondo KK, Saha S, et al
    Racial and Ethnic Disparities in COVID-19-Related Infections, Hospitalizations, and Deaths : A Systematic Review.
    Ann Intern Med. 2020 Dec 1. doi: 10.7326/M20-6306.
    PubMed         Abstract available
    
    
11. BARNABAS RV, Brown ER, Bershteyn A, Stankiewicz Karita HC, et al
    Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.
    Ann Intern Med. 2020 Dec 8. doi: 10.7326/M20-6519.
    PubMed         Abstract available
    
    
12. 
    Summary for Patients: Postexposure Hydroxychloroquine Prophylaxis to Prevent SARS-CoV-2 Infection.
    Ann Intern Med. 2020 Dec 8. doi: 10.7326/P20-0015.
    PubMed        
    
    
13. LARGENT EA, Halpern SD, Lynch HF
    Waivers and Alterations of Research Informed Consent During the COVID-19 Pandemic.
    Ann Intern Med. 2020 Dec 15. doi: 10.7326/M20-6993.
    PubMed        
    
    
14. SENAY E, Sarfaty M, Rice MB
    Strategies for Clinical Discussions About Climate Change.
    Ann Intern Med. 2021;174:417-418.
    PubMed        
    
    
15. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
    Ann Intern Med. 2021 Jan 25. doi: 10.7326/M21-0331.
    PubMed        
    
    

    
    Antimicrob Agents Chemother

16. YAN VC, Muller FL
    Remdesivir for COVID-19: Why Not Dose Higher?
    Antimicrob Agents Chemother. 2021;65.
    PubMed        
    
    
17. DORGHAM K, Neumann AU, Decavele M, Luyt CE, et al
    Considering Personalized Interferon Beta Therapy for COVID-19.
    Antimicrob Agents Chemother. 2021;65.
    PubMed        
    
    
18. JUNEJA K, Humeniuk R, Porter D, Cao H, et al
    Reply to Yan and Muller, "Remdesivir for COVID-19: Why Not Dose Higher?"
    Antimicrob Agents Chemother. 2021;65.
    PubMed        
    
    
19. DAVOUDI-MONFARED E, Khalili H
    Reply to Dorgham et al., "Considering Personalized Interferon Beta Therapy for COVID-19".
    Antimicrob Agents Chemother. 2021;65.
    PubMed        
    
    

    
    Biochem Soc Trans

20. MANFREDONIA I, Incarnato D
    Structure and regulation of coronavirus genomes: state-of-the-art and novel insights from SARS-CoV-2 studies.
    Biochem Soc Trans. 2021;49:341-352.
    PubMed         Abstract available
    
    

    
    BMJ

21. CARROLL D, Morzaria S, Briand S, Johnson CK, et al
    Preventing the next pandemic: the power of a global viral surveillance network.
    BMJ. 2021;372:n485.
    PubMed        
    
    
22. MUNRO C, Burke J, Allum W, Mortensen N, et al
    Covid-19 leaves surgical training in crisis.
    BMJ. 2021;372:n659.
    PubMed        
    
    
23. KORINEK A, Stiglitz JE
    Covid-19 driven advances in automation and artificial intelligence risk exacerbating economic inequality.
    BMJ. 2021;372:n367.
    PubMed        
    
    
24. CAVE S, Whittlestone J, Nyrup R, O hEigeartaigh S, et al
    Using AI ethically to tackle covid-19.
    BMJ. 2021;372:n364.
    PubMed        
    
    
25. KRASS M, Henderson P, Mello MM, Studdert DM, et al
    How US law will evaluate artificial intelligence for covid-19.
    BMJ. 2021;372:n234.
    PubMed        
    
    
26. LESLIE D, Mazumder A, Peppin A, Wolters MK, et al
    Does "AI" stand for augmenting inequality in the era of covid-19 healthcare?
    BMJ. 2021;372:n304.
    PubMed        
    
    
27. KHUNTI K, Griffiths A, Majeed A, Nagpaul C, et al
    Assessing risk for healthcare workers during the covid-19 pandemic.
    BMJ. 2021;372:n602.
    PubMed        
    
    
28. DARBY AC, Hiscox JA
    Covid-19: variants and vaccination.
    BMJ. 2021;372:n771.
    PubMed        
    
    
29. HIGGINS GC, Ho J, Robertson E, McLean N, et al
    Covid-19: Health and social care workers need, want, and deserve reusable FFP3 respirators.
    BMJ. 2021;372:n759.
    PubMed        
    
    
30. FANG L, Pinder A, Cooper G, McGrath B, et al
    Mitigating the environmental impact of plastic PPE: more than just disposal.
    BMJ. 2021;372:n752.
    PubMed        
    
    
31. MACKENZIE DG
    Using key concepts from the Marmot review to frame covid-19 response.
    BMJ. 2021;372:n795.
    PubMed        
    
    
32. FORBES H, Morton CE, Bacon S, McDonald HI, et al
    Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England.
    BMJ. 2021;372:n628.
    PubMed         Abstract available
    
    
33. PIMENTA D, Yates C, Pagel C, Gurdasani D, et al
    Delaying the second dose of covid-19 vaccines.
    BMJ. 2021;372:n710.
    PubMed        
    
    
34. FINNIKIN S, Spiegelhalter DJ
    What is my covid risk?
    BMJ. 2021;372:n637.
    PubMed        
    
    
35. REQUEJO J, Strong K
    Redesigning health programmes for all children and adolescents.
    BMJ. 2021;372:n533.
    PubMed        
    
    
36. ULYTE A, Radtke T, Abela IA, Haile SR, et al
    Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.
    BMJ. 2021;372:n616.
    PubMed         Abstract available
    
    
37. FEDER G, Lucas d'Oliveira AF, Rishal P, Johnson M, et al
    Domestic violence during the pandemic.
    BMJ. 2021;372:n722.
    PubMed        
    
    

    
    Drugs

38. LAMB YN
    BNT162b2 mRNA COVID-19 Vaccine: First Approval.
    Drugs. 2021;81:495-501.
    PubMed         Abstract available
    
    

    
    Epidemiol Infect

39. ZHAO K, Ai L, Zhao Y, Wang T, et al
    Diagnostic value of using a combination of nucleic acid and specific antibody tests for SARS-CoV-2 in coronavirus disease 2019.
    Epidemiol Infect. 2021;149:e62.
    PubMed         Abstract available
    
    
40. KUCHENHOFF H, Gunther F, Hohle M, Bender A, et al
    Analysis of the early COVID-19 epidemic curve in Germany by regression models with change points.
    Epidemiol Infect. 2021;149:e68.
    PubMed         Abstract available
    
    
41. KOZER E, Rinott E, Kozer G, Bar-Haim A, et al
    Presence of SARS-CoV-2 RNA on playground surfaces and water fountains.
    Epidemiol Infect. 2021;149:e67.
    PubMed         Abstract available
    
    
42. MICHOS A, Savvidou P, Syridou G, Eleftheriou E, et al
    SARS-CoV-2 molecular testing in Greek hospital paediatric departments: a nationwide study.
    Epidemiol Infect. 2021;149:e70.
    PubMed         Abstract available
    
    
43. GAO Y, Chen Y, Liu M, Niu M, et al
    Nervous system diseases are associated with the severity and mortality of patients with COVID-19: a systematic review and meta-analysis.
    Epidemiol Infect. 2021;149:e66.
    PubMed         Abstract available
    
    
44. LELIS DA SILVA F, Dias Pita J, Gomes MDA, Lelis da Silva AP, et al
    Intraregional propagation of Covid-19 cases in Para, Brazil: assessment of isolation regime to lockdown.
    Epidemiol Infect. 2021;149:e72.
    PubMed         Abstract available
    
    

    
    J Exp Med

45. POON MML, Farber DL
    Lasting memories of SARS-CoV-2 infection.
    J Exp Med. 2021;218.
    PubMed         Abstract available
    
    

    
    J Infect

46. GUETL K, Moazedi-Fuerst F, Rosskopf K, Brodmann M, et al
    SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30684.
    PubMed        
    
    
47. CHEN CH, Lai CC, Chao CM, Tang HJ, et al
    Zero measles after COVID-19 pandemic in Taiwan Running title: measles and COVID-19.
    J Infect. 2020 Oct 26. pii: S0163-4453(20)30679.
    PubMed        
    
    
48. ALFEHAIDI A, Ahmed SA, Hamed E
    A case of SARS-CoV-2 re-infection.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30677.
    PubMed        
    
    
49. MASIA M, Fernandez-Gonzalez M, Garcia JA, Padilla S, et al
    Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30676.
    PubMed        
    
    
50. MORFELD P, Timmermann B, Gross JV, DeMatteis S, et al
    COVID-19: Spatial resolution of excess mortality in Germany and Italy.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30678.
    PubMed        
    
    
51. WELLBELOVE Z, Walsh C, Perinpanathan T, Lillie P, et al
    Comparing the 4C mortality score for COVID-19 to established scores (CURB65, CRB65, qSOFA, NEWS) for respiratory infection patients.
    J Infect. 2020 Oct 25. pii: S0163-4453(20)30673.
    PubMed        
    
    
52. MELE M, Henares D, Pino R, Asenjo S, et al
    Low impact of SARS-CoV-2 infection among paediatric acute respiratory disease hospitalizations.
    J Infect. 2020 Oct 21. pii: S0163-4453(20)30655.
    PubMed         Abstract available
    
    
53. RANA MS, Usman M, Alam MM, Ikram A, et al
    Impact of COVID-19 pandemic on Measles surveillance in Pakistan.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30650.
    PubMed        
    
    
54. SONG W, Jia X, Zhang X, Ling Y, et al
    Co-infection in COVID-19, a cohort study.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30648.
    PubMed        
    
    
55. JIA X, Xiao L, Liu Y
    False negative RT-PCR and false positive antibody tests-Concern and solutions in the diagnosis of COVID-19.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30649.
    PubMed        
    
    
56. BI J, Wang S, Wang Y, Yang D, et al
    Effect of Administering Subsequent Immune Checkpoint Inhibition in Cancer Patients with Prior COVID-19 Infection.
    J Infect. 2020 Oct 8. pii: S0163-4453(20)30647.
    PubMed        
    
    
57. MAO MH, Guo JJ, Qin LZ, Han ZX, et al
    Serial semiquantitative detection of SARS-CoV-2 in saliva samples.
    J Infect. 2020 Oct 5. pii: S0163-4453(20)30644.
    PubMed        
    
    
58. MIYAZAWA DD
    Letter in response to article in journal of infection: "Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study".
    J Infect. 2020 Sep 27. pii: S0163-4453(20)30637.
    PubMed        
    
    
59. MERLI M, Pasulo L, Perricone G, Travi G, et al
    Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30685.
    PubMed        
    
    
60. DIMEGLIO C, Loubes JM, Mansuy JM, Izopet J, et al
    Quantifying the impact of public health protection measures on the spread of SARS-CoV-2.
    J Infect. 2020 Oct 28. pii: S0163-4453(20)30686.
    PubMed         Abstract available
    
    
61. ADRIELLE DOS SANTOS L, Filho PGG, Silva AMF, Santos JVG, et al
    Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers.
    J Infect. 2021 Feb 9. pii: S0163-4453(21)00043.
    PubMed         Abstract available
    
    
62. BULILETE O, Lorente P, Leiva A, Carandell E, et al
    Panbio rapid antigen test for SARS-CoV-2 has acceptable accuracy in symptomatic patients in primary health care.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00080.
    PubMed         Abstract available
    
    
63. ANTONELLI M, Capdevila J, Chaudhari A, Granerod J, et al
    Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohort.
    J Infect. 2021 Feb 13. pii: S0163-4453(21)00079.
    PubMed         Abstract available
    
    
64. MORENO-PEREZ O, Merino E, Leon-Ramirez JM, Andres M, et al
    Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study.
    J Infect. 2021 Jan 12. pii: S0163-4453(21)00009.
    PubMed         Abstract available
    
    
65. GANDINI O, Lubrano C
    Use of rapid ferritin test to predict clinical deterioration in at home COVID-19 patients.
    J Infect. 2020 Dec 20. pii: S0163-4453(20)30775.
    PubMed        
    
    
66. TURCATO G, Zaboli A, Pfeifer N, Ciccariello L, et al
    Clinical application of a rapid antigen test for the detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients evaluated in the emergency department: a preliminary report.
    J Infect. 2020 Dec 18. pii: S0163-4453(20)30773.
    PubMed        
    
    
67. FURUSE Y
    Risk at mass-gathering events and the usefulness of complementary events during COVID-19 pandemic.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30759.
    PubMed        
    
    
68. MAANI AA, Al-Jardani A, Karrar H, Petersen E, et al
    COVID-19 in a case previously infected with MERS-CoV: no cross immunity.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30754.
    PubMed        
    
    
69. DUBOUCHER C
    SARS-CoV-2 and superimposed infection by trichomonads.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30757.
    PubMed        
    
    
70. DAHDOUH E, Lazaro-Perona F, Romero-Gomez MP, Mingorance J, et al
    Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load.
    J Infect. 2020 Oct 24. pii: S0163-4453(20)30675.
    PubMed        
    
    
71. GANDINI O, Criniti A, Gagliardi MC, Ballesio L, et al
    Sex-disaggregated data confirm serum ferritin as an independent predictor of disease severity both in male and female COVID-19 patients.
    J Infect. 2020 Oct 22. pii: S0163-4453(20)30654.
    PubMed        
    
    
72. KOWALL B, Nonnemacher M, Brune B, Brinkmann M, et al
    A model to identify individuals with a high probability of a SARS-CoV-2 infection.
    J Infect. 2020 Nov 24. pii: S0163-4453(20)30721.
    PubMed        
    
    
73. BELSKY JA, Tullius BP, Lamb MG, Sayegh R, et al
    COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients.
    J Infect. 2021 Feb 4. pii: S0163-4453(21)00045.
    PubMed         Abstract available
    
    
74. ROMERO-GOMEZ MP, Gomez-Sebastian S, Cendejas-Bueno E, Montero-Vega MD, et al
    Ct value is not enough to discriminate patients harbouring infective virus.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30720.
    PubMed        
    
    
75. BERASTEGUI-CABRERA J, Salto-Alejandre S, Valerio M, Perez-Palacios P, et al
    SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load.
    J Infect. 2020 Nov 25. pii: S0163-4453(20)30719.
    PubMed        
    
    
76. LAI CC, Chen SY, Yen MY, Lee PI, et al
    The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan.
    J Infect. 2020 Nov 26. pii: S0163-4453(20)30724.
    PubMed        
    
    
77. JONES CR, Hamilton FW, Thompson A, Morris TT, et al
    SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: a sociodemographic analysis.
    J Infect. 2020 Nov 30. pii: S0163-4453(20)30755.
    PubMed        
    
    

    
    J Infect Dis

78. LAMOTH F, Lewis RE, Walsh TJ, Kontoyiannis DP, et al
    Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA).
    J Infect Dis. 2021 Mar 26. pii: 6189669. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

79. SLAINE PD, Kleer M, Duguay BA, Pringle ES, et al
    Thiopurines activate an antiviral unfolded protein response that blocks influenza A virus glycoprotein accumulation.
    J Virol. 2021 Mar 24. pii: JVI.00453-21. doi: 10.1128/JVI.00453.
    PubMed         Abstract available
    
    

    
    J Virol Methods

80. OLADUNNI FS, Park JG, Chiem K, Ye C, et al
    Selection, identification, and characterization of SARS-CoV-2 monoclonal antibody resistant mutants.
    J Virol Methods. 2021;290:114084.
    PubMed         Abstract available
    
    
81. NIMSAMER P, Mayuramart O, Rattanaburi S, Chantaravisoot N, et al
    Comparative performance of CRISPR-Cas12a assays for SARS-CoV-2 detection tested with RNA extracted from clinical specimens.
    J Virol Methods. 2021;290:114092.
    PubMed         Abstract available
    
    
82. ZWIRGLMAIER K, Weyh M, Kruger C, Ehmann R, et al
    Rapid detection of SARS-CoV-2 by pulse-controlled amplification (PCA).
    J Virol Methods. 2021;290:114083.
    PubMed         Abstract available
    
    
83. BURTON J, Love H, Richards K, Burton C, et al
    The effect of heat-treatment on SARS-CoV-2 viability and detection.
    J Virol Methods. 2021;290:114087.
    PubMed         Abstract available
    
    
84. HON KL, Leung KKY, Tang JW, Leung AKC, et al
    COVID-19 in Hong Kong - Public health, food safety, and animal vectors perspectives.
    J Virol Methods. 2021;290:114036.
    PubMed         Abstract available
    
    
85. DOGAN OA, Kose B, Agaoglu NB, Yildiz J, et al
    Does sampling saliva increase detection of SARS-CoV-2 by RT-PCR? Comparing saliva with oro-nasopharyngeal swabs.
    J Virol Methods. 2021;290:114049.
    PubMed         Abstract available
    
    
86. TOZETTO-MENDOZA TR, Kanunfre KA, Vilas-Boas LS, Sanchez Espinoza EP, et al
    Nucleoprotein-based ELISA for detection of SARS-COV-2 IgG antibodies: Could an old assay be suitable for serodiagnosis of the new coronavirus?
    J Virol Methods. 2021;290:114064.
    PubMed         Abstract available
    
    
87. PERE H, Mboumba Bouassa RS, Tonen-Wolyec S, Podglajen I, et al
    Analytical performances of five SARS-CoV-2 whole-blood finger-stick IgG-IgM combined antibody rapid tests.
    J Virol Methods. 2021;290:114067.
    PubMed         Abstract available
    
    

    
    JAMA

88. USCHER-PINES L, Sousa J, Jones M, Whaley C, et al
    Telehealth Use Among Safety-Net Organizations in California During the COVID-19 Pandemic.
    JAMA. 2021 Feb 2. pii: 2776166. doi: 10.1001/jama.2021.0282.
    PubMed        
    
    
89. RASMUSSEN SA, Jamieson DJ
    Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021.
    JAMA. 2021 Feb 8. pii: 2776447. doi: 10.1001/jama.2021.1683.
    PubMed        
    
    
90. ADHIKARI EH, Spong CY
    COVID-19 Vaccination in Pregnant and Lactating Women.
    JAMA. 2021 Feb 8. pii: 2776449. doi: 10.1001/jama.2021.1658.
    PubMed        
    
    
91. BIANCHI DW, Kaeser L, Cernich AN
    Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.
    JAMA. 2021 Feb 10. pii: 2776540. doi: 10.1001/jama.2021.1865.
    PubMed        
    
    
92. MURAI IH, Fernandes AL, Sales LP, Pinto AJ, et al
    Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial.
    JAMA. 2021 Feb 17. pii: 2776738. doi: 10.1001/jama.2020.26848.
    PubMed         Abstract available
    
    
93. WALENSKY RP, Walke HT, Fauci AS
    SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities.
    JAMA. 2021 Feb 17. pii: 2776739. doi: 10.1001/jama.2021.2294.
    PubMed        
    
    
94. RUBIN R
    Pregnant People's Paradox-Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications.
    JAMA. 2021 Feb 24. pii: 2777024. doi: 10.1001/jama.2021.2264.
    PubMed        
    
    
95. SLOMSKI A
    Molecular Point-of-Care Test Improved Influenza Care.
    JAMA. 2021;325:1135.
    PubMed        
    
    
96. WILENSKY GR
    2020 Revealed How Poorly the US Was Prepared for COVID-19-and Future Pandemics.
    JAMA. 2021;325:1029-1030.
    PubMed        
    
    
97. ANGUS DC, Gordon AC, Bauchner H
    Emerging Lessons From COVID-19 for the US Clinical Research Enterprise.
    JAMA. 2021 Feb 26. pii: 2777058. doi: 10.1001/jama.2021.3284.
    PubMed        
    
    
98. FELDSTEIN LR, Tenforde MW, Friedman KG, Newhams M, et al
    Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
    JAMA. 2021 Feb 24. pii: 2777026. doi: 10.1001/jama.2021.2091.
    PubMed         Abstract available
    
    

    
    Lancet

99. MOLYNEUX DH, Eberhard ML, Cleaveland S, Addey R, et al
    Certifying Guinea worm eradication: current challenges.
    Lancet. 2020;396:1857-1860.
    PubMed        
    
    
100. FONTANET A, Autran B, Lina B, Kieny MP, et al
     SARS-CoV-2 variants and ending the COVID-19 pandemic.
     Lancet. 2021 Feb 11. pii: S0140-6736(21)00370.
     PubMed        
     
     
101. WOUTERS OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, et al
     Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
     Lancet. 2021 Feb 12. pii: S0140-6736(21)00306.
     PubMed         Abstract available
     
     
102. 
     Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.
     Lancet. 2021 Feb 12. pii: S0140-6736(21)00388.
     PubMed        
     
     
103. GODDARD AF, Patel M
     The changing face of medical professionalism and the impact of COVID-19.
     Lancet. 2021 Feb 23. pii: S0140-6736(21)00436.
     PubMed        
     
     
104. MADAD S, Spencer C
     The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response.
     Lancet. 2021 Mar 5. pii: S0140-6736(21)00433.
     PubMed        
     
     
105. THE LANCET
     Access to COVID-19 vaccines: looking beyond COVAX.
     Lancet. 2021;397:941.
     PubMed        
     
     
106. GILL PS, Poduval S, Thakur JS, Iqbal R, et al
     COVID-19, community trials, and inclusion.
     Lancet. 2021;397:1036-1037.
     PubMed        
     
     
107. STRUGNELL R, Wang N
     Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2.
     Lancet. 2021;397:1037-1039.
     PubMed        
     
     

     
     MMWR Morb Mortal Wkly Rep

108. SIEGEL M, Kloppenburg B, Woerle S, Sjoblom S, et al
     Notes from the Field: SARS-CoV-2 Transmission Associated with High School Football Team Members - Florida, September-October 2020.
     MMWR Morb Mortal Wkly Rep. 2021;70:402-404.
     PubMed        
     
     
109. DEUTSCH-FELDMAN M, Pratt RH, Price SF, Tsang CA, et al
     Tuberculosis - United States, 2020.
     MMWR Morb Mortal Wkly Rep. 2021;70:409-414.
     PubMed         Abstract available
     
     
110. FUKUNAGA R, Glaziou P, Harris JB, Date A, et al
     Epidemiology of Tuberculosis and Progress Toward Meeting Global Targets - Worldwide, 2019.
     MMWR Morb Mortal Wkly Rep. 2021;70:427-430.
     PubMed         Abstract available
     
     
111. DAWSON P, Worrell MC, Malone S, Tinker SC, et al
     Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020.
     MMWR Morb Mortal Wkly Rep. 2021;70:449-455.
     PubMed         Abstract available
     
     
112. DOYLE T, Kendrick K, Troelstrup T, Gumke M, et al
     COVID-19 in Primary and Secondary School Settings During the First Semester of School Reopening - Florida, August-December 2020.
     MMWR Morb Mortal Wkly Rep. 2021;70:437-441.
     PubMed         Abstract available
     
     
113. HUGHES MM, Wang A, Grossman MK, Pun E, et al
     County-Level COVID-19 Vaccination Coverage and Social Vulnerability - United States, December 14, 2020-March 1, 2021.
     MMWR Morb Mortal Wkly Rep. 2021;70:431-436.
     PubMed         Abstract available
     
     
114. DIRLIKOV E, Jahun I, Odafe SF, Obinna O, et al
     Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic - Nine States, Nigeria, March 31, 2019-September 30, 2020.
     MMWR Morb Mortal Wkly Rep. 2021;70:421-426.
     PubMed         Abstract available
     
     
115. 
     QuickStats: Age-Adjusted Death Rates* for Influenza and Pneumonia,(dagger) by Urbanization Level( section sign) and Sex - National Vital Statistics System, United States, 2019.
     MMWR Morb Mortal Wkly Rep. 2021;70:456.
     PubMed        
     
     
116. HERSHOW RB, Wu K, Lewis NM, Milne AT, et al
     Low SARS-CoV-2 Transmission in Elementary Schools - Salt Lake County, Utah, December 3, 2020-January 31, 2021.
     MMWR Morb Mortal Wkly Rep. 2021;70:442-448.
     PubMed         Abstract available
     
     

     
     N Engl J Med

117. VAN TASSEL K, Shachar C, Hoffman S
     Covid-19 Vaccine Injuries - Preventing Inequities in Compensation.
     N Engl J Med. 2021 Jan 20. doi: 10.1056/NEJMp2034438.
     PubMed        
     
     
118. LUNDGREN JD, Grund B, Barkauskas CE, Holland TL, et al
     A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
     N Engl J Med. 2020 Dec 22. doi: 10.1056/NEJMoa2033130.
     PubMed         Abstract available
     
     
119. POOLE MK, Fleischhacker SE, Bleich SN
     Addressing Child Hunger When School Is Closed - Considerations during the Pandemic and Beyond.
     N Engl J Med. 2021;384:e35.
     PubMed        
     
     
120. RUBIN EJ, Baden LR, Abraham J, Morrissey S, et al
     Audio Interview: The Implications of Changes in the Structural Biology of SARS-CoV-2.
     N Engl J Med. 2021;384:e48.
     PubMed        
     
     
121. CARTER S
     Breathless.
     N Engl J Med. 2021;384:891-893.
     PubMed        
     
     

     
     PLoS Comput Biol

122. STURNIOLO S, Waites W, Colbourn T, Manheim D, et al
     Testing, tracing and isolation in compartmental models.
     PLoS Comput Biol. 2021;17:e1008633.
     PubMed         Abstract available
     
     
123. DING J, Hostallero DE, El Khili MR, Fonseca GJ, et al
     A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes' interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19.
     PLoS Comput Biol. 2021;17:e1008810.
     PubMed         Abstract available
     
     
124. RICHARD Q, Alizon S, Choisy M, Sofonea MT, et al
     Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic.
     PLoS Comput Biol. 2021;17:e1008776.
     PubMed         Abstract available
     
     

     
     PLoS Med

125. REID M, Abdool-Karim Q, Geng E, Goosby E, et al
     How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
     PLoS Med. 2021;18:e1003564.
     PubMed         Abstract available
     
     

     
     PLoS One

126. PARK J, Lee SH, You SC, Kim J, et al
     Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea.
     PLoS One. 2021;16:e0248058.
     PubMed         Abstract available
     
     
127. EDER SJ, Steyrl D, Stefanczyk MM, Pieniak M, et al
     Predicting fear and perceived health during the COVID-19 pandemic using machine learning: A cross-national longitudinal study.
     PLoS One. 2021;16:e0247997.
     PubMed         Abstract available
     
     
128. BRAGA MB, Fernandes RDS, Souza GN Jr, Rocha JECD, et al
     Artificial neural networks for short-term forecasting of cases, deaths, and hospital beds occupancy in the COVID-19 pandemic at the Brazilian Amazon.
     PLoS One. 2021;16:e0248161.
     PubMed         Abstract available
     
     
129. MASCIANTONIO A, Bourguignon D, Bouchat P, Balty M, et al
     Don't put all social network sites in one basket: Facebook, Instagram, Twitter, TikTok, and their relations with well-being during the COVID-19 pandemic.
     PLoS One. 2021;16:e0248384.
     PubMed         Abstract available
     
     
130. TSAI MC
     Developing a sustainability strategy for Taiwan's tourism industry after the COVID-19 pandemic.
     PLoS One. 2021;16:e0248319.
     PubMed         Abstract available
     
     
131. DEFAR A, Molla G, Abdella S, Tessema M, et al
     Knowledge, practice and associated factors towards the prevention of COVID-19 among high-risk groups: A cross-sectional study in Addis Ababa, Ethiopia.
     PLoS One. 2021;16:e0248420.
     PubMed         Abstract available
     
     
132. JUUL S, Nielsen EE, Feinberg J, Siddiqui F, et al
     Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
     PLoS One. 2021;16:e0248132.
     PubMed         Abstract available
     
     
133. GRIMES DR
     Medical disinformation and the unviable nature of COVID-19 conspiracy theories.
     PLoS One. 2021;16:e0245900.
     PubMed         Abstract available
     
     
134. ALNAZLY E, Khraisat OM, Al-Bashaireh AM, Bryant CL, et al
     Anxiety, depression, stress, fear and social support during COVID-19 pandemic among Jordanian healthcare workers.
     PLoS One. 2021;16:e0247679.
     PubMed         Abstract available
     
     
135. NATNAEL T, Alemnew Y, Berihun G, Abebe M, et al
     Facemask wearing to prevent COVID-19 transmission and associated factors among taxi drivers in Dessie City and Kombolcha Town, Ethiopia.
     PLoS One. 2021;16:e0247954.
     PubMed         Abstract available
     
     
136. LEULSEGED TW, Hassen IS, Ayele BT, Tsegay YG, et al
     Laboratory biomarkers of COVID-19 disease severity and outcome: Findings from a developing country.
     PLoS One. 2021;16:e0246087.
     PubMed         Abstract available
     
     
137. HOEBEN EM, Bernasco W, Suonpera Liebst L, van Baak C, et al
     Social distancing compliance: A video observational analysis.
     PLoS One. 2021;16:e0248221.
     PubMed         Abstract available
     
     
138. SAEGERMAN C, Gilbert A, Donneau AF, Gangolf M, et al
     Clinical decision support tool for diagnosis of COVID-19 in hospitals.
     PLoS One. 2021;16:e0247773.
     PubMed         Abstract available
     
     
139. MUN EY, Geng F
     An epidemic model for non-first-order transmission kinetics.
     PLoS One. 2021;16:e0247512.
     PubMed         Abstract available
     
     
140. PRESTON S, Anderson A, Robertson DJ, Shephard MP, et al
     Detecting fake news on Facebook: The role of emotional intelligence.
     PLoS One. 2021;16:e0246757.
     PubMed         Abstract available
     
     
141. HARPER H, Burridge A, Winfield M, Finn A, et al
     Detecting SARS-CoV-2 variants with SNP genotyping.
     PLoS One. 2021;16:e0243185.
     PubMed         Abstract available
     
     
142. PAGANI G, Giacomelli A, Conti F, Bernacchia D, et al
     Prevalence of SARS-CoV-2 in an area of unrestricted viral circulation: Mass seroepidemiological screening in Castiglione d'Adda, Italy.
     PLoS One. 2021;16:e0246513.
     PubMed         Abstract available
     
     
143. OSMAN AH, Aljahdali HM, Altarrazi SM, Ahmed A, et al
     SOM-LWL method for identification of COVID-19 on chest X-rays.
     PLoS One. 2021;16:e0247176.
     PubMed         Abstract available
     
     
144. SHEIN SL, Whitticar S, Mascho KK, Pace E, et al
     The effects of wearing facemasks on oxygenation and ventilation at rest and during physical activity.
     PLoS One. 2021;16:e0247414.
     PubMed         Abstract available
     
     
145. DIMKE H, Larsen SL, Skov MN, Larsen H, et al
     Phenol-chloroform-based RNA purification for detection of SARS-CoV-2 by RT-qPCR: Comparison with automated systems.
     PLoS One. 2021;16:e0247524.
     PubMed         Abstract available
     
     
146. TOSCANO JC, Toscano CM
     Effects of face masks on speech recognition in multi-talker babble noise.
     PLoS One. 2021;16:e0246842.
     PubMed         Abstract available
     
     
147. NOURY A, Francois A, Gergaud O, Garel A, et al
     How does COVID-19 affect electoral participation? evidence from the French municipal elections.
     PLoS One. 2021;16:e0247026.
     PubMed         Abstract available
     
     
148. SONI S, Jiang Y, Tesfaigzi Y, Hornick JL, et al
     Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis.
     PLoS One. 2021;16:e0247510.
     PubMed         Abstract available
     
     
149. PARANJPE I, Chaudhary K, Johnson KW, Jaladanki SK, et al
     Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury: A retrospective cohort study.
     PLoS One. 2021;16:e0247366.
     PubMed         Abstract available
     
     
150. FAZIO RH, Ruisch BC, Moore CA, Granados Samayoa JA, et al
     Who is (not) complying with the U. S. social distancing directive and why? Testing a general framework of compliance with virtual measures of social distancing.
     PLoS One. 2021;16:e0247520.
     PubMed         Abstract available
     
     
151. YAREN O, McCarter J, Phadke N, Bradley KM, et al
     Ultra-rapid detection of SARS-CoV-2 in public workspace environments.
     PLoS One. 2021;16:e0240524.
     PubMed         Abstract available
     
     
152. HART J
     Did the COVID-19 pandemic help or hurt Donald Trump's political fortunes?
     PLoS One. 2021;16:e0247664.
     PubMed         Abstract available
     
     
153. ADEBOWALE OO, Adenubi OT, Adesokan HK, Oloye AA, et al
     SARS-CoV-2 (COVID-19 pandemic) in Nigeria: Multi-institutional survey of knowledge, practices and perception amongst undergraduate veterinary medical students.
     PLoS One. 2021;16:e0248189.
     PubMed         Abstract available
     
     
154. FIORILLI G, Grazioli E, Buonsenso A, Di Martino G, et al
     A national COVID-19 quarantine survey and its impact on the Italian sports community: Implications and recommendations.
     PLoS One. 2021;16:e0248345.
     PubMed         Abstract available
     
     
155. DE VITO A, Fiore V, Princic E, Geremia N, et al
     Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes.
     PLoS One. 2021;16:e0248009.
     PubMed         Abstract available
     
     
156. SHINJOH M, Sugaya N, Yamaguchi Y, Ookawara I, et al
     Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018/19 season.
     PLoS One. 2021;16:e0249005.
     PubMed         Abstract available
     
     
157. SHOJI M, Esumi T, Tanaka N, Takeuchi M, et al
     Organic synthesis and anti-influenza A virus activity of cyclobakuchiols A, B, C, and D.
     PLoS One. 2021;16:e0248960.
     PubMed         Abstract available
     
     
158. ROWLINSON E, Peters L, Mansour A, Mansour H, et al
     Comparison of common acute respiratory infection case definitions for identification of hospitalized influenza cases at a population-based surveillance site in Egypt.
     PLoS One. 2021;16:e0248563.
     PubMed         Abstract available
     
     
159. NOVAES DE AMORIM A, Deardon R, Saini V
     A stacked ensemble method for forecasting influenza-like illness visit volumes at emergency departments.
     PLoS One. 2021;16:e0241725.
     PubMed         Abstract available
     
     
160. SCHULER CF 4TH, Gherasim C, O'Shea K, Manthei DM, et al
     Accurate point-of-care serology tests for COVID-19.
     PLoS One. 2021;16:e0248729.
     PubMed         Abstract available
     
     
161. PU J, Mei H, Lei L, Li D, et al
     Knowledge of medical professionals, their practices, and their attitudes toward traditional Chinese medicine for the prevention and treatment of coronavirus disease 2019: A survey in Sichuan, China.
     PLoS One. 2021;16:e0234855.
     PubMed         Abstract available
     
     
162. KHEIR M, Saleem F, Wang C, Mann A, et al
     Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19.
     PLoS One. 2021;16:e0248358.
     PubMed         Abstract available
     
     
163. HUANG LS, Li L, Dunn L, He M, et al
     Taking account of asymptomatic infections: A modeling study of the COVID-19 outbreak on the Diamond Princess cruise ship.
     PLoS One. 2021;16:e0248273.
     PubMed         Abstract available
     
     
164. OSIBOGUN A, Balogun M, Abayomi A, Idris J, et al
     Outcomes of COVID-19 patients with comorbidities in southwest Nigeria.
     PLoS One. 2021;16:e0248281.
     PubMed         Abstract available
     
     
165. FEYISA ZT
     Factors limiting youths' practice of preventive measures toward the outbreak of COVID-19 in Oromia special zone surrounding Finfinnee, Ethiopia.
     PLoS One. 2021;16:e0248495.
     PubMed         Abstract available
     
     
166. TUASON MT, Guss CD, Boyd L
     Thriving during COVID-19: Predictors of psychological well-being and ways of coping.
     PLoS One. 2021;16:e0248591.
     PubMed         Abstract available
     
     
167. RODRIGUEZ J, Paton M, Uratani JM, Acuna JM, et al
     Modelling the impact of interventions on the progress of the COVID-19 outbreak including age segregation.
     PLoS One. 2021;16:e0248243.
     PubMed         Abstract available
     
     
168. MENG F, Gong W, Liang J, Li X, et al
     Impact of different control policies for COVID-19 outbreak on the air transportation industry: A comparison between China, the U.S. and Singapore.
     PLoS One. 2021;16:e0248361.
     PubMed         Abstract available
     
     
169. PIGOZZI E, Tregnago D, Costa L, Insolda J, et al
     Psychological impact of Covid-19 pandemic on oncological patients: A survey in Northern Italy.
     PLoS One. 2021;16:e0248714.
     PubMed         Abstract available
     
     

     
     Proc Natl Acad Sci U S A

170. CASTRO MC, Singer B
     Prioritizing COVID-19 vaccination by age.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed        
     
     
171. LIU R, Americo JL, Cotter CA, Earl PL, et al
     One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
172. LU M, Dravid P, Zhang Y, Trivedi S, et al
     A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed         Abstract available
     
     
173. WEISEL O
     Vaccination as a social contract: The case of COVID-19 and US political partisanship.
     Proc Natl Acad Sci U S A. 2021;118.
     PubMed        
     
     

     
     Vaccine

174. GRAUPENSPERGER S PHD, Abdallah DA, Lee CM
     Social norms and vaccine uptake: College students' COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine.
     Vaccine. 2021 Mar 17. pii: S0264-410X(21)00286.
     PubMed         Abstract available
     
     
175. CAMBOU MC, Copeland TP, Nielsen-Saines K, Macinko J, et al
     Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018.
     Vaccine. 2021 Mar 17. pii: S0264-410X(21)00294.
     PubMed         Abstract available
     
     
176. CHEN D, Ye Z, Pi Z, Mizukami S, et al
     Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China.
     Vaccine. 2021 Mar 20. pii: S0264-410X(21)00324.
     PubMed         Abstract available
     
     
177. KENDAL A
     Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs.
     Vaccine. 2021 Mar 20. pii: S0264-410X(21)00283.
     PubMed        
     
     
178. KUTER BJ, Browne S, Momplaisir FM, Feemster KA, et al
     Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia.
     Vaccine. 2021 Feb 16. pii: S0264-410X(21)00185.
     PubMed         Abstract available
     
     

     
     Virus Res

179. LANDGRAF G, Desheva YA, Rudenko LG
     Evaluation of influenza A and B cold-adapted reassortant virus reproduction in trivalent live influenza vaccines.
     Virus Res. 2021 Mar 17:198396. doi: 10.1016/j.virusres.2021.198396.
     PubMed         Abstract available
     
     
180. SCAGNOLARI C, Pierangeli A, Frasca F, Bitossi C, et al
     Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19).
     Virus Res. 2021;295:198283.
     PubMed         Abstract available
     
     
181. LI JY, Wang Q, Liao CH, Qiu Y, et al
     The 442th amino acid residue of the spike protein is critical for the adaptation to bat hosts for SARS-related coronaviruses.
     Virus Res. 2021;295:198307.
     PubMed         Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: